Role of dietary intake and intestinal absorption of oxalate in calcium stone formation

Nephron - Physiology

Volumn 98, Issue 2, 2004, Pages

  Jaeger, Ph ^a   Robertson, W G ^a,b  

^a UNIVERSITY HOSPITAL OF NICE   (France)

^b INSTITUTE OF UROLOGY AND NEPHROLOGY   (United Kingdom)

Author keywords

Calcium; Fibre; Intestinal absorption; Magnesium; Oxalate; pH; Urolithiasis

Indexed keywords

CALCIUM; CALCIUM OXALATE; MAGNESIUM; OXALIC ACID; PHOSPHATE;

BIOAVAILABILITY; CALCIUM INTAKE; CALCIUM STONE; CONCENTRATION RESPONSE; DIETARY INTAKE; FECES; FOOD INTAKE; HUMAN; INTESTINE ABSORPTION; INTESTINE FLORA; INTESTINE SECRETION; OXALOBACTER FORMIGENES; PATHOGENESIS; PH; PHOSPHATE INTAKE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; URINARY EXCRETION; URINE LEVEL;

ANIMALS; CALCIUM; CALCULI; DIET; HUMANS; INTESTINAL ABSORPTION; OXALATES;

EID: 7544234887     PISSN: 16602137     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080266     Document Type: Review

References (66)

1. Robertson WG, Peacock M, Heyburn PJ, Marshall DH, Clark PB: Risk factors in calcium stone disease of the urinary tract. Br J Urol 1978;50:449-454.
2. Robertson WG, Peacock M: The cause of idiopathic calcium stone disease: Hypercalciuria or hyperoxaluria? Nephron 1980;26:105-110.
3. Siener R, Ebert D, Nicolay C, Hesse A: Dietary risk factors for hyperoxaluria in calcium oxalate stone formers. Kidney Int 2003;63:1037-1043.
4. Hodgkinson A: Oxalic Acid in Biology and Medicine. London, Academic Press, 1977.
5. Zarembski PM, Hodgkinson A: The oxalic acid content of English diets. Br J Nutr 1962;16:627-634.
6. Holmes RP, Kennedy M: Estimation of the oxalate content of foods and daily oxalate intake. Kidney Int 2000;57:1662-1667.
7. Holmes RP, Goodman HO, Assimos DG: Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int 2001;59:270-276.
8. Massey LK: Dietary influences on urinary oxalate and risk of kidney stones. Front Biosci 2003;8:s584-s594.
9. Marshall RW, Cochran M, Hodgkinson A: Relationship between calcium and oxalic acid intake in the diet and their excretion in the urine of normal and renal stone-forming subjects. Clin Sci 1972;43:91-99.
10. Berg W, Bothor C, Pirlich W, Janitzky V: Influence of magnesium on the absorption and excretion of calcium and oxalate ions. Eur Urol 1986;12:274-282.
11. Hanson CF, Frankos VH, Thompson WO: Bioavailability of oxalic acid from spinach, sugar beet fibre and a solution of sodium oxalate consumed by female volunteers. Food Chem Toxicol 1989;27:181-184.
12. Hautmann RE: The stomach: A new and powerful oxalate absorption site in man. J Urol 1993;149:1401-1404.
13. Hatch M, Freel RW, Vaziri ND: Mechanisms of oxalate absorption and secretion across the rabbit distal colon. Pflügers Arch 1994;426:101-109.
14. Allison MJ, Dawson KA, Mayberry WR, Foss JG: Oxalobacter formigenes gen. nov., sp. nov.: Oxalate-degrading anaerobes that inhabit the gastrointestinal tract. Arch Microbiol 1985;141:1-7.
15. Allison MJ, Cook HM, Milne DB, Gallagher S, Clayman RV: Oxalate degradation by gastrointestinal bacteria from humans. J Nutr 1986;116:455-460.
16. Robertson WG, Scurr DS: Prevention of ascorbic acid interference in the measurement of oxalic acid in urine by ion-chromatography. Clin Chim Acta 1984;140:97-99.
17. Hughes H, Hagen L, Sutton RAL: Determination of urinary oxalate by high performance liquid chromatography. Anal Biochem 1982;119:1-3.
18. Holmes RP, Goodman HO, Assimos DG: Dietary oxalate and its intestinal absorption. Scan Microsc 1995;9:1109-1118.
19. 2] oxalate. J Am Soc Nephrol 1999;10(suppl 14):S329-S333.
20. Hodgkinson A: Sampling errors in the determination of urine calcium and oxalate: Solubility of calcium oxalate in HCl-urine mixtures. Clin Chim Acta 1981;109:239-244.
21. Robertson WG: Mild hyperoxaluria: A critical review and future outlook; in Borghi L, Meschi T, Briganti A, Schianchi T, Novarini A (eds): Kidney Stones. Cosenza, Editoriale Bios, 1999, pp 33-42.
22. Robertson WG, Nordin BEC: Activity products in urine; in Hodgkinson A, Nordin BEC (eds): Proceedings of the Renal Stone Research Symposium. London, Churchill, 1969, pp 221-232.
23. Hallson PC, Rose GA: Chemical measurement of calcium oxalate crystalluria: Results in various causes of calcium urolithiasis. Urol Int 1990;45:332-335.
24. Lemann J, Pleuss JA, Worcester EM, Hornick L, Schrab D, Hoffmann RG: Urinary oxalate excretion increases with body size and decreases with increasing dietary calcium intake among healthy adults. Kidney Int 1996;49:200-208.
25. Leonetti F, Dussol B, Berthezene P, Thirion X, Berland Y: Dietary and urinary risk factors for stones in idiopathic calcium stone formers compared with healthy subjects. Nephrol Dial Transplant 1998;13:617-622.
26. Neuhaus TJ, Belzer T, Blau N, Hoppe B, Sidhu H, Leumann E: Urinary oxalate excretion in urolithiasis and nephrocalcinosis. Arch Dis Child 2000;82:322-326.
27. Brzezinski E, Durning AM, Grasse B, Fusselman, Ciaraldi T: Oxalate Content of Selected Foods. San Diego, University of California at San Diego, 1998.
28. Terris MK, Issa MM, Tacker JR: Dietary supplementation with cranberry concentrate tablets may increase the risk of nephrolithiasis. Urology 2001;57:26-29.
29. Harris KS, Richardson KE: Glycolate in the diet and its conversion to urinary oxalate in the rat. Invest Urol 1980;18:106-109.
30. Robertson WG, Heyburn PJ, Peacock M, Hanes F, Swaminathan R: The effect of a high animal protein intake on the risk of calcium stone-formation in the urinary tract. Clin Sci 1979;57:285-288.
31. Nguyen Q-V, Kälin A, Drouve U, Casez J-P, Jaeger Ph: Sensitivity to meat protein intake and hyperoxaluria in idiopathic calcium stoneformers. Kidney Int 2001;59:2273-2281.
32. Marangella M, Bianco O, Martini C, Petrarulo M, Vitale C, Linari F: Effect of animal and vegetable protein on oxalate excretion in idiopathic calcium stone disease. Br J Urol 1989;63:348-351.
33. Urivetsky M, Kessaris D, Smith AD: Ascorbic acid overdosing: A risk factor for calcium oxalate nephrolithiasis. J Urol 1992;147:1215-1218.
34. Auer BL, Auer D, Rodgers AL: Relative hyperoxaluria, crystalluria and haematuria after megadose ingestion of vitamin C. Eur J Clin Invest 1998;28:695-700.
35. Traxer O, Huet B, Poindexter J, Pak CYC, Pearle MS: Effect of ascorbic acid consumption on urinary stone risk factors. J Urol 2003;170:397-401.
36. 6, and the risk of kidney stones in men. J Urol 1996;155:1847-1851.
37. Gerster H: No contribution of ascorbic acid to renal calcium oxalate stones. Ann Nutr Metab 1997;41:269-282.
38. Mazzachi BC, Teubner JK, Ryall RL: The effect of ascorbic acid on urine oxalate measurement; in Schwille PO, Smith JH, Robertson WG, Vahlensieck W (eds): Urolithiasis and Related Clinical Research. New York, Plenum Press, 1985, pp 649-652.
39. Hatch M, Freel RW: Alterations in intestinal transport of oxalate in disease states. Scan Microsc 1995;9:1121-1126.
40. Chen Z, Ye Z, Zeng L, Yang W: Clinical investigation on gastric oxalate absorption. Chin Med J (Engl) 2003;116:1749-1751.
41. Liebman M, Costa G: Effects of calcium and magnesium on urinary oxalate excretion after oxalate loads. J Urol 2000;163:1565-1569.
42. Diamond KL, Fox CC, Barch DH: Role of cecal pH in intestinal oxalate absorption in the rat. J Lab Clin Med 1988;112:352-356.
43. Siener R, Glatz S, Nicolay C, Hesse A: The role of overweight and obesity in calcium oxalate stone formation. Obes Res 2004;12:106-113.
44. Brinkley L, McGuire J, Gregory J, Pak CYC: Bioavailability of oxalate in foods. Urology 1981;17:534-538.
45. Hossain RZ, Ogawa Y, Morozumi M, Sugaya K, Hatano T: Urinary oxalic acid differs after oral loading of rats with various oxalate salts. Int J Urol 2003;10:43-48.
46. Savage GP, Charrier MJ, Vanhanen L: Bioavailability of soluble oxalate from tea and the effect of consuming milk with the tea. Eur J Clin Nutr 2003;57:415-419.
47. Brogren M, Savage GP: Bioavailability of soluble oxalate from spinach eaten with an without milk products. Asia Pac J Nutr 2003;12:219-224.
48. Gleeson MJ, Thompson AS, Mehta S, Griffith DP: Effect of unprocessed wheat bran on calciuria and oxaluria in patients with urolithiasis. Urology 1990;35:231-234.
49. Jahnen A, Heynck H, Gertz B, Classen A, Hesse A: Dietary fibre: The effectiveness of a high bran intake in reducing renal calcium excretion. Urol Res 1992;20:3-6.
50. Robertson WG, Hughes H, Husain I, Al-Faqih S, Arafat A, Chakrabarti A, Shamsuddin A, Tipton L: Simultaneous treatment of calcium oxalate and uric acid stone disease in Saudi Arabia; in Ryall R, Bais R, Marshall VR, Rofe AM, Smith LH, Walker VR (eds): Urolithiasis 2. New York, Plenum Press, 1994, pp 581-586.
51. Hess B, Jost C, Zipperle L, Takkinen R, Jaeger Ph: High-calcium intake abolishes hyperoxaluria and reduces urinary crystallization during a 20-fold normal oxalate load in humans. Nephrol Dial Transplant 1998;13:2241-2247.
52. Siener R, Jahnen A, Hesse A: Influence of a mineral water rich in calcium, magnesium and bicarbonate on urine composition and the risk of calcium oxalate crystallization. Eur J Clin Nutr 2004;58:270-276.
53. Erickson SB, Cooper K, Broadus AE, Smith LH, Werness PG, Binder HJ, Dobbins JW: Oxalate absorption and postprandial urine supersaturation in an experimental human model of absorptive hypercalciuria. Clin Sci 1984;67:131-138.
54. Robertson WG, Hughes H: Importance of mild hyperoxaluria in the pathogenesis of urolithiasis: New evidence from studies in the Arabian Peninsula. Scanning Microsc 1993;7:391-402.
55. Baetz AL, Allison MJ: Purification and characterization of oxalyl-coenzyme A decarboxylase fro Oxalobacter formigenes. J Bacteriol 1989;171:2605-2608.
56. Stewart CS, Duncan SH, Cave DR: Oxalobacter formigenes and its role in oxalate metabolism in the human gut. FEMS Microbiol Lett 2004;230:1-7.
57. Kwak C, Kim HK, Kim EC, Choi MS, Kim HH: Urinary oxalate levels and the enteric bacterium Oxalobacter formigenes in patients with calcium oxalate urolithiasis. Eur Urol 2003;44:475-481.
58. Kumar R, Mukherjee M, Bhandari M, Kumar A, Sidhu H, Mittal RD: Role of Oxalobacter formigenes in calcium oxalate stone disease: A study from North India. Eur Urol 2002;41:318-322.
59. Troxel SA, Sidhu H, Kaul P, Low RK: Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate. J Endourol 2003;17:173-176.
60. Mikami K, Akakura K, Takei K, Ueda T, Mizoguchi K, Noda M, Miyake M, Ito H: Association of absence of intestinal oxalate degrading bacteria with urinary calcium oxalate stone formation. Int J Urol 2003;10:293-296.
61. Siener R, Ebert D, Hesse A: Urinary oxalate excretion in female calcium oxalate stone formers with and without a history of recurrent urinary tract infections. Urol Res 2001;29:245-248.
62. Robertson WG, Whitfield HN, Unwin RJ, Mansell MA, Neild GH: The changing pattern of urinary stone disease in the UK and its causes. Br J Urol Int 2000;85(suppl 5):37-38.
63. Sidhu H, Hoppe B, Hesse A, Tenbrock K, Bromme S, Rietschel E, Peck AB: Absence of Oxalobacter formigenes in cystic fibrosis patients: A risk factor for hyperoxaluria. Lancet 1998;352:1026-1029.
64. Sidhu H, Schmidt ME, Cornelius, Thamiselvan S, Khan SR, Hesse A, Peck AB: Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: Possible prevention by gut recolonization or enzyme replacement therapy. J Am Soc Nephrol 1999;10(suppl 14):S334-S340.
65. Campieri C, Campieri M, Bertuzzi V, Swennen E, Matteuzzi D, Stefoni S, Pirovano F, Centi C, Ulisse S, Famularo G, De Simone C: Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration. Kidney Int 2001;60:1097-1105.
66. Hokama S, Honma Y, Toma C, Ogawa Y: Oxalate-degrading Enterococcus faecalis. Microbiol Immunol 2000;44:235-240.